Memantine (Namenda) for moderate to severe Alzheimer's disease
Ables, A.Z.
American Family Physician 69(6): 1491-1492
2004
ISSN/ISBN: 0002-838X PMID: 15053415 Document Number: 572211
Document emailed within 1 workday
Related Documents
Creţu, O.; Szalontay, A.S.; Chiriţă, R.; Chiriţă, V. 2008: Effect of memantine treatment on patients with moderate-to-severe Alzheimer's disease treated with donepezil Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 112(3): 641-645Tanović, A.; Alfaro, V. 2006: Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia Revista de Neurologia 42(10): 607-616
Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Bachyns'ka, N.I.; Rozheliuk, I.F.; Polietaieva, K.M.; Kholin, V.O. 2013: Use of memantine for elderly patients in the mild stage of Alzheimer's and vascular dementia Likars'ka Sprava 7: 80-96
Erickson, R.P.; Sandman, R.; Langer, L.O. 1975: A lysosomal storage disease with severe dwarfism, severe joint contractures, mild-moderate mental retardation, corneal opacities and retinal abnormalities Birth Defects Original Article Series 11(6): 317-324
Henigsberg, N.; Kalember, P.; Hrabać, P.; Rados, M.; Bajs, M.; Rados, M.; Kovavić, Z.; Loncar, M.; Madzar, T. 2011: 1-H MRS changes in dorsolateral prefrontal cortex after donepezil treatment in patients with mild to moderate Alzheimer's disease Collegium Antropologicum 35(Suppl 1): 159-162
De La Sayette, V.; Bouvier, F.; Eustache, F.; Morin, I.; Morin, P. 1991: Severe amblyopia and Alzheimer' disease Revue Neurologique (Paris) 147(11): 747-751
Villars, H.; Gillioz, A-S.; Hein, C.; Voisin, T.; Nourhashemi, F.; Soto, M-E.; Arbus, C.; Ousset, P-J.; Vellas, B. 2008: Alzheimer's disease and syndromes related to the severe stage Revue Neurologique (Paris) 164(Special Issue 2): F98-106
Lulseged, S. 1992: Predictors of moderate to severe dehydration in acute diarrhoeal disease: a case-control study Ethiopian Medical Journal 30(2): 69-78
Greszata, L.; Stępińska, J. 2015: Moderate or severe aquired valvular heart disease in pregnancy--what does determine the management? Experence, intuition or guidelines? Przeglad Lekarski 72(4): 189-192
Cottone, S.; Palermo, A.; Arsena, R.; Riccobene, R.; Guarneri, M.; Mulè, G.; Tornese, F.; Altieri, C.; Vaccaro, F.; Previti, A.; Previti, A.; Cerasola, G. 2010: Relationship of fetuin-A with glomerular filtration rate and endothelial dysfunction in moderate-severe chronic kidney disease Journal of Nephrology 23(1): 62-69
Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Fukatsu, R.; Tsuzuki, K.; Hayashi, Y.; Takamaru, Y.; Sasaki, N.; Yoshida, T.; Hatakeyama, Y.; Fuji, N.; Takahata, N. 1997: Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes Hokkaido Journal of Medical Science 72(1): 3-11
Morris, J.C.; Edland, S.; Clark, C.; Galasko, D.; Koss, E.; Mohs, R.; van Belle, G.; Fillenbaum, G.; Heyman, A. 1993: The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43(12): 2457-2465
Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. 1988: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacology Bulletin 24(4): 641-652
Miyakawa, T. 1988: Brain pathology in Alzheimer's disease. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1471-1474
Torchio, R.; Gulotta, C.; Parvis, M.; Pozzi, R.; Giardino, R.; Borasio, P.; Greco Lucchina, P. 1998: Gas exchange threshold as a predictor of severe postoperative complications after lung resection in mild-to-moderate chronic obstructive pulmonary disease Monaldi Archives for Chest Disease 53(2): 127-133
Szpak, G.M.; Lechowicz, W.; Lewandowska, E.; Bertrand, E.; Wierzba-Bobrowicz, T.; Gwiazda, E.; Schmidt-Sidor, B.; Dymecki, J. 2001: Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study Folia Neuropathologica 39(3): 181-192
Bufill, E.; Blesa, R. 2006: Alzheimer's disease and brain evolution: is Alzheimer's disease an example of antagonistic pleiotropy? Revista de Neurologia 42(1): 25-33
Koch, H.J.; Szecsey, A.; Raschka, C. 2001: Severe bradyarrhythmia in a patient with Alzheimer's disease and a patient with cerebral ischaemia, both induced by acute distension of the bladder International Journal of Clinical Practice 55(5): 323-325